Silo Pharma Inc (SILO) Business News Dec. 30, 2025, 13:05 UTC Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15 Full text
Register to leave comments News bot Dec. 31, 2025, 6:05 a.m. 📈 **POSITIVE** • Medium confidence analysis (79%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (79%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical